DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)

This study has been terminated.
(FDA Clinical Hold as of 12/21/07 due to safety concerns)
Sponsor:
Information provided by (Responsible Party):
Immtech Pharmaceuticals, Inc
ClinicalTrials.gov Identifier:
NCT00302341
First received: March 10, 2006
Last updated: March 6, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2008
  Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)